FDA Adverse Event Malfunction Summary report: N

QUADRA ASSURA MP

MDR report key: 11045936 · Received December 21, 2020

Report

Report Number
2938836-2020-09787
Event Type
Malfunction
Date Received
December 21, 2020
Report Date
December 21, 2020
Manufacturer
ABBOTT
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

FURTHER INFORMATION WAS REQUESTED BUT IS NOT AVAILABLE. THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.

Description of Event or Problem · 1

DURING FOLLOW-UP, POST-SENSED T-WAVE OVERSENSING WAS OBSERVED AND WAS RESOLVED BY PROGRAMMING BRADYCARDIA SENSITIVITY. DURING ANOTHER FOLLOW-UP, PRE-SYNCOPE DUE TO PACING INHIBITION WAS REPORTED DUE TO NON-SUSTAINED OVERSENSING (NSRVOS) DUE TO EXTERNAL NOISE. DEFIBRILLATION THERAPY WAS NOT DELIVERED DUE TO CORRECT INTERPRETATION OF OVERSENSING BY THE DEVICE. THE EVENT WAS RESOLVED BY REPROGRAMMING THE DEVICE. THE PATIENT WAS IN STABLE CONDITION. DETAILS ARE LISTED IN THE ARTICLE TITLED "DEALING WITH RV-OVERSENSING; SEPARATE SENSITIVITY SETTINGS FOR BRADY AND TACHY SENSING. J CARDIOVASC ELECTROPHYSIOL. 2020; 1¿ 3. HTTPS://DOI.ORG/10.1111/JCE.14823".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1517811 QUADRA ASSURA MP IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS ABBOTT QUADRA ASSURA MP

Patients

Seq Age Sex Outcome Treatment
1